Literature DB >> 10634794

Sol Sherry Lecture in Thrombosis : research on clot stabilization provides clues for improving thrombolytic therapies.

L Lorand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10634794     DOI： 10.1161/01.atv.20.1.2

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  10 in total

1.  The elasticity of an individual fibrin fiber in a clot.

Authors:  Jean-Philippe Collet; Henry Shuman; Robert E Ledger; Seungtaek Lee; John W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

2.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

Authors:  Jean-Philippe Collet; Jennifer L Moen; Yuri I Veklich; Oleg V Gorkun; Susan T Lord; Gilles Montalescot; John W Weisel
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

3.  Barnacle cement: a polymerization model based on evolutionary concepts.

Authors:  Gary H Dickinson; Irving E Vega; Kathryn J Wahl; Beatriz Orihuela; Veronica Beyley; Eva N Rodriguez; Richard K Everett; Joseph Bonaventura; Daniel Rittschof
Journal:  J Exp Biol       Date:  2009-11       Impact factor: 3.312

Review 4.  Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.

Authors:  Molly McAdow; Dominique M Missiakas; Olaf Schneewind
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

5.  Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.

Authors:  N J Mutch; J S Koikkalainen; S R Fraser; K M Duthie; M Griffin; J Mitchell; H G Watson; N A Booth
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

6.  Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).

Authors:  Ralf Pasternack; Christian Büchold; Robert Jähnig; Christiane Pelzer; Michael Sommer; Andreas Heil; Peter Florian; Götz Nowak; Uwe Gerlach; Martin Hils
Journal:  J Thromb Haemost       Date:  2019-10-23       Impact factor: 5.824

7.  Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.

Authors:  Martina Leitner; Christian Büchold; Ralf Pasternack; Nikolaus B Binder; Gary W Moore
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

8.  Advantages of Fibrin Polymerization Method without the Use of Exogenous Thrombin for Vascular Tissue Engineering Applications.

Authors:  Vera G Matveeva; Evgenia A Senokosova; Viktoriia V Sevostianova; Mariam Yu Khanova; Tatiana V Glushkova; Tatiana N Akentieva; Larisa V Antonova; Leonid S Barbarash
Journal:  Biomedicines       Date:  2022-03-28

9.  Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.

Authors:  Rustem I Litvinov; Rosa M Nabiullina; Laily D Zubairova; Mileusha A Shakurova; Izabella A Andrianova; John W Weisel
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

Review 10.  Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.

Authors:  Fahad S M Alshehri; Claire S Whyte; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.